Source: BIOPORTFOLIO

VuCOMP: VuCOMP Announces Milestone for Development of ComputerAided Detection for Breast Tomosynthesis

VuCOMP Inc. leading developer of advanced computer vision systems for the detection of breast cancer is pleased to announce the successful completion of the development of structured reporting SR for CAD marks for digital breast tom...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Jeffrey C. Wehnes's photo - Co-Founder & CEO of VuCOMP

Co-Founder & CEO

Jeffrey C. Wehnes

CEO Approval Rating

68/100

Read more